SSRI Treatment for Suicidal Ideation with Hopelessness and Low Energy

Assessment and Risk Stratification

A thorough suicide risk assessment should be conducted to determine the severity of suicidal ideation, presence of plans, and risk factors for suicide attempt, as recommended by the American Academy of Child and Adolescent Psychiatry 1, 2
Patients with older age, male gender, previous suicide attempts, and continued desire to die are at higher risk for suicide, according to the American Academy of Child and Adolescent Psychiatry 1
Multiple assessment methods, including clinical interviews and standardized measures, should be used to determine suicide risk, as suggested by the American College of Physicians 2, 3

SSRIs are recommended as first-line pharmacological treatment for suicidal ideation with depression due to their low lethality in overdose and effectiveness in treating depression, as recommended by the American Academy of Child and Adolescent Psychiatry 4, 5
The American Academy of Child and Adolescent Psychiatry recommends that tricyclic antidepressants should NOT be used as first-line treatment due to their lethality in overdose 4, 5
Medications that may increase disinhibition or impulsivity, such as benzodiazepines and phenobarbital, should be prescribed with caution, as advised by the American Academy of Child and Adolescent Psychiatry 4, 5

Psychotherapy, including cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), and interpersonal therapy (IPT-A), should be combined with medication management for optimal outcomes, as recommended by the American College of Physicians 2, 3, 4, 5
Crisis response planning, including removing access to lethal means and establishing a support system, should be implemented, as suggested by the American Academy of Child and Adolescent Psychiatry 1, 2, 5

Patients with bipolar disorder should always be treated with a mood stabilizer, such as lithium or valproate, in combination with an SSRI to prevent triggering mania, as recommended by the American Psychiatric Association 6
Lithium has specific anti-suicidal properties and should be considered for patients with bipolar disorder or recurrent unipolar depression with suicidality, as suggested by the American College of Physicians 2, 3

Frequent follow-up appointments should be scheduled, especially during the first month of treatment, as recommended by the American Academy of Child and Adolescent Psychiatry 1, 5
The treating clinician should be available to the patient and family outside of regular hours or ensure adequate coverage, as advised by the American Academy of Child and Adolescent Psychiatry 4, 5
Treatment should be continued until mental state and suicidality have stabilized, with long-term maintenance treatment as indicated by diagnosis, as recommended by the American Academy of Child and Adolescent Psychiatry 1